Page last updated: 2024-09-03

reboxetine and Atherosclerotic Parkinsonism

reboxetine has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bayindirli, D; Caykoylu, A; Deniz, O; Ekinci, O; Kuloglu, M; Vural, G	1

Other Studies

1 other study(ies) available for reboxetine and Atherosclerotic Parkinsonism

Article	Year
Successful management of depression with reboxetine in a patient who developed Parkinsonism related to paroxetine use. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:4 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Humans; Male; Middle Aged; Morpholines; Parkinson Disease, Secondary; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2010

Article

Year

Successful management of depression with reboxetine in a patient who developed Parkinsonism related to paroxetine use.

Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:4

Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Humans; Male; Middle Aged; Morpholines; Parkinson Disease, Secondary; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome

2010